ARS Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
SPRY
CUSIP
82835W108
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 5 60.1 k $1.01 M
2025 Q1 193 76.3 M $960 M
2024 Q4 178 71.3 M $752 M
2024 Q3 166 64.1 M $928 M
2024 Q2 127 62.8 M $534 M
2024 Q1 124 60.1 M $615 M
2023 Q4 110 67.3 M $369 M
2023 Q3 108 66.5 M $252 M
2023 Q2 101 55.1 M $369 M
2023 Q1 97 53.4 M $348 M
2022 Q4 77 50.3 M $429 M
2022 Q3 65 30.4 M $160 M
2022 Q2 70 26.1 M $111 M
2022 Q1 72 27.0 M $94.7 M
2021 Q4 76 30.1 M $200 M
2021 Q3 76 28.9 M $288 M
2021 Q2 77 28.0 M $865 M
2021 Q1 69 27.7 M $1.21 B
2020 Q4 64 24.6 M $1.13 B